Company Close Updates

Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market

Company Logo

Terrence Horan

Referenced Symbols

Shares of Vertex Pharmaceuticals Inc. VRTX, -0.80% inched 0.24% higher to $188.86 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.15% rising 0.85% to 4,480.70 and the Dow Jones Industrial Average DJIA, +0.10% rising 0.68% to 34,814.39. Vertex Pharmaceuticals Inc. closed $92.13 below its 52-week high ($280.99), which the company reached on October 13th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, -0.30% rose 0.38% to $165.42, Merck & Co. Inc. MRK, +0.77% rose 0.97% to $72.81, and AbbVie Inc. ABBV, -0.27% rose 1.21% to $107.77. Trading volume (1.6 M) remained 279,488 below its 50-day average volume of 1.9 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.